PMID- 8912672 OWN - NLM STAT- MEDLINE DCOM- 19961226 LR - 20190501 IS - 0264-6021 (Print) IS - 1470-8728 (Electronic) IS - 0264-6021 (Linking) VI - 319 ( Pt 2) IP - Pt 2 DP - 1996 Oct 15 TI - Lysophosphatidic acid-sensitive intracellular Ca2+ store does not regulate Ca2+ entry at plasma membrane in Jurkat human T-cells. PG - 393-7 AB - In Jurkat T cells, the anti-CD3 antibody OKT3 and thapsigargin (TG) elevated the cytoplasmic free Ca2+ concentration ([Ca2+]i), after which it decreased to a sustained, elevated level. In contrast, lysophosphatidic acid (LPA) increased [Ca2+]i only briefly and transiently, after which it declined to the resting level of [Ca2+]i even in the presence of extracellular Ca2+. OKT3 increased Ins(1,4,5)P3 formation but neither LPA nor TG did. In the absence of extracellular Ca2+, the addition of OKT3 did not affect an elevation of [Ca2+]i induced by the subsequent addition of LPA and vice versa. In permeabilized Jurkat cells, the addition of Ins(1,4,5)P3 released Ca2+; this was inhibited by heparin, whereas LPA released Ca2+ even in the presence of heparin. cADP-ribose released Ca2+; this was additive with LPA-induced Ca2+ release and vice versa in permeabilized Jurkat cells. LPA did not stimulate Ca2+ entry and 45Ca2+ uptake but OKT3 and TG did. LPA, OKT3 and TG did not affect the sustained elevation of [Ca2+]i induced by ionomycin. The present results suggest that at least three kinds of intracellular Ca2+ stores, which are Ins(1,4,5)P3,-cADP-ribose- and LPA-sensitive, exist in Jurkat T cells, and that the LPA-sensitive intracellular Ca2+ store does not regulate Ca2+ entry at the plasma membrane. FAU - Takemura, H AU - Takemura H AD - Department of Pharmacology, School of Medicine, Sapporo Medical University, Japan. FAU - Imoto, K AU - Imoto K FAU - Sakano, S AU - Sakano S FAU - Kaneko, M AU - Kaneko M FAU - Ohshika, H AU - Ohshika H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (CD3 Complex) RN - 0 (Lysophospholipids) RN - 0 (Muromonab-CD3) RN - SY7Q814VUP (Calcium) SB - IM MH - CD3 Complex/metabolism MH - Calcium/*metabolism MH - Humans MH - Ion Transport/drug effects MH - Jurkat Cells MH - Lysophospholipids/*pharmacology MH - Muromonab-CD3/pharmacology MH - Signal Transduction/*drug effects MH - T-Lymphocytes/*metabolism PMC - PMC1217781 EDAT- 1996/10/15 00:00 MHDA- 1996/10/15 00:01 PMCR- 1997/04/15 CRDT- 1996/10/15 00:00 PHST- 1996/10/15 00:00 [pubmed] PHST- 1996/10/15 00:01 [medline] PHST- 1996/10/15 00:00 [entrez] PHST- 1997/04/15 00:00 [pmc-release] AID - 10.1042/bj3190393 [doi] PST - ppublish SO - Biochem J. 1996 Oct 15;319 ( Pt 2)(Pt 2):393-7. doi: 10.1042/bj3190393.